BAUSCH HEALTH AMERICAS, INC.
(CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets
- First Posted Date
- 2010-04-08
- Last Posted Date
- 2019-11-29
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT01100112
- Locations
- 🇮🇳
Santarus Clinical Investigational Site 9015, Karnataka, India
🇮🇳Santarus Clinical Investigational Site 9001, Andhra Pradesh, India
🇮🇳Santarus Clinical Investigational Site 9009, Andhra Pradesh, India
SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation
- Conditions
- Interventions
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2020-01-02
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT01053962
- Locations
- 🇺🇸
A.G.A. Clinical Trials, Hialeah, Florida, United States
🇺🇸DCOL Center for Clinical Research, Longview, Texas, United States
🇺🇸Pioneer Research Solutions, Sugar Land, Texas, United States
Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
- First Posted Date
- 2009-11-05
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 265
- Registration Number
- NCT01008410
Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
- First Posted Date
- 2009-11-05
- Last Posted Date
- 2019-08-14
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 281
- Registration Number
- NCT01008423
Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)
- First Posted Date
- 2009-11-04
- Last Posted Date
- 2019-11-12
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT01007448
- Locations
- 🇺🇸
Tulane, New Orleans, Louisiana, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Duke University, Durham, North Carolina, United States
Study to Evaluate Efficacy and Safety in Male Subjects With Premature Ejaculation
- Conditions
- Interventions
- First Posted Date
- 2009-09-24
- Last Posted Date
- 2012-08-27
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 1050
- Registration Number
- NCT00983736
- Locations
- 🇧🇬
MHAT Plovdiv, Plovdiv, Bulgaria
🇷🇴Spitalul Clinic de Urgenta Militar Central "Dr. Carol Davila", Bucuresti, Romania
🇨🇿Psychiatricke Oddeienf and Sexuologicka Ambulance, Pardubice, Czech Republic
Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation
- First Posted Date
- 2009-09-23
- Last Posted Date
- 2012-08-27
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 1050
- Registration Number
- NCT00983151
- Locations
- 🇫🇷
11 rue Magellan, Paris, France
🇧🇪Ziekenhuisnelwerk Antwerpen (ZNA), Campus Stuvenberg-St. Erasmus, Antwerpen, Belgium
🇫🇷Institut de Medecine Sexuelle, Marseille, France
Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2009-09-11
- Last Posted Date
- 2019-06-26
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 198
- Registration Number
- NCT00975637
Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face
- Conditions
- Interventions
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2012-02-15
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 162
- Registration Number
- NCT00952523
- Locations
- 🇺🇸
Skin Study Center, Broomall, Pennsylvania, United States
Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation
- First Posted Date
- 2009-07-10
- Last Posted Date
- 2020-01-02
- Lead Sponsor
- Bausch Health Americas, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT00936884